BioCardia, Inc. Logo

BioCardia, Inc.

Develops cell-derived therapeutics for cardiovascular and pulmonary diseases.

BCDA | US

Overview

Corporate Details

ISIN(s):
US09060U5074
LEI:
Country:
United States of America
Address:
320 SOQUEL WAY, 94085 SUNNYVALE

Description

BioCardia, Inc. is a clinical-stage regenerative medicine company that develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. The company's lead program is the CardiAMP® cell therapy system, an autologous therapy that uses a patient's own bone marrow cells to potentially stimulate the body's natural healing response in the heart. This therapy is primarily being evaluated for the treatment of ischemic heart failure. In addition to its autologous platform, BioCardia is also developing CardiALLO™, an allogeneic cell therapy platform using cells from qualified donors. The company's approach integrates biotherapeutic candidates with proprietary delivery systems for targeted administration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-16 09:00
FORM 8-K
English ZIP 75.3 KB
2025-12-10 22:54
FORM 4
English ZIP 7.8 KB
2025-12-10 22:54
FORM 4
English ZIP 7.7 KB
2025-12-10 22:54
FORM 4
English ZIP 7.7 KB
2025-12-10 22:53
FORM 4
English ZIP 6.9 KB
2025-12-10 22:52
FORM 4
English ZIP 7.1 KB
2025-12-10 22:52
FORM 4
English ZIP 7.0 KB
2025-12-10 22:52
FORM 4
English ZIP 7.0 KB
2025-12-10 22:51
FORM 4
English ZIP 7.0 KB
2025-12-10 22:51
FORM 4
English ZIP 7.1 KB
2025-12-10 22:48
FORM 3
English ZIP 10.1 KB
2025-12-03 09:00
FORM 8-K
English ZIP 78.3 KB
2025-11-24 09:00
FORM 8-K
English ZIP 66.6 KB
2025-11-12 17:10
FORM 8-K
English ZIP 95.9 KB
2025-11-12 17:07
FORM 10-Q
English ZIP 757.1 KB

Automate Your Workflow. Get a real-time feed of all BioCardia, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BioCardia, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BioCardia, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.